zolucatetide

all catalysts(0)

nothing on the calendar yet

News(3)

• Scribe reels in nearly $129M in rare early-stage IPO for a gene editing biotech
  Jennifer Doudna–founded Scribe Therapeutics intends to use the proceeds from the public offering—the first for a gene editing outfit in over two years—to support development of its epigenetic silen…
  biospace · 18d ago
• Parabilis sets a record with a $670M biotech IPO
  The largest-ever new stock sale for a venture-backed biotech company extends a streak of large IPOs in 2026 that’s now resulted in 12 drug startups securing more than $4.1 billion combined.
  biopharma_dive · 2mo ago
• Fierce Biotech Fundraising Tracker '26: Vaderis nets $152M series B; Epicrispr adds $90M
  The Fierce Biotech Fundraising Tracker records venture capital rounds of $50 million or more secured by biotechs.
  fiercebiotech · 7mo ago